SNCA and Parkinson disease: Rare duplications and triplications of SNCA (Singleton et al., 2003) also cause PD with a ‘dosage effect’ (Box 1): greater numbers of SNCA copies, causing increasing endogenous levels of α-synuclein, have been associated with earlier and more severe clinical symptoms (Eriksen et al., 2005).